Analyst Ratings for Arcus Biosciences (RCUS)
RCUS Rating Summary
RCUS Price Target Summary
- Highest: $47.00 (Leerink)
- Lowest: $22.00 (Morgan Stanley)
- Average: $35.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$35.11 (+23.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$35.11 (+23.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | Truist Securities | Supawat Thongthip | New Coverage | Buy (N/A) |
35.00 (N/A) |
23.78 (28.42) |
19.51% | Details |
| 2/12/2026 | Wells Fargo | Jason Hass | Downgrade | Equal Weight (Overweight) |
23.00 (30.00) |
21.36 (28.42) |
33.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
